|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
1994-4-28
|
|
pubmed:abstractText |
Anemia of prematurity is characterized by low reticulocyte counts and inadequate erythropoietin response, for which many very-low-birth-weight infants receive multiple blood transfusions. We investigated whether early treatment of such infants with recombinant human erythropoietin would reduce their need for transfusions.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
28
|
|
pubmed:volume |
330
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1173-8
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8139627-Anemia, Neonatal,
pubmed-meshheading:8139627-Blood Transfusion,
pubmed-meshheading:8139627-Cost-Benefit Analysis,
pubmed-meshheading:8139627-Erythropoietin,
pubmed-meshheading:8139627-Female,
pubmed-meshheading:8139627-Humans,
pubmed-meshheading:8139627-Infant, Low Birth Weight,
pubmed-meshheading:8139627-Infant, Newborn,
pubmed-meshheading:8139627-Infant, Premature, Diseases,
pubmed-meshheading:8139627-Injections, Subcutaneous,
pubmed-meshheading:8139627-Iron,
pubmed-meshheading:8139627-Male,
pubmed-meshheading:8139627-Recombinant Proteins,
pubmed-meshheading:8139627-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
|
|
pubmed:affiliation |
Universitätsklinikum Rudolf Virchow, Freie Universität Berlin, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
